Comar expands packaging solutions with Omega acquisition
The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise
The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise
Adbry is the first biologic launched by LEO Pharma in the United States and is expected to be available in pharmacies by February 2022
Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients
Medical footprint expansion with deeper medical grade skin contact material science expertise
Ichnos will receive an upfront payment of Euro 20.8 million as well as additional development and commercial milestone payments and tiered royalties based upon future global sales
Saroglitazar Mg is an investigational compound in the USA, and is yet to be approved by the U.S. Food & Drug Administration (USFDA) or European Medicines Agency (EMA)
Transaction adds to Sanofi pipeline a potential first-in-class vaccine candidate in acne vulgaris, a condition affecting millions of people worldwide
Applications supported by positive results from the pivotal Phase 3 POETYK-PSO clinical trial program demonstrating superior efficacy of deucravacitinib over Otezla (apremilast)
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
India registers 18% of deaths annually due to air pollution while seven million die annually across the world due to air pollution
Subscribe To Our Newsletter & Stay Updated